Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
REGENXBIO | RGNX | Nov 15, 2024 | 9.63 | -13.55 |
Regional Health Properties | RHE | Nov 15, 2024 | 1.57 | +12.14 |
Regional Health Properties A Pref | RHE-A | Nov 15, 2024 | 0.45 | 0.00 |
Regional Management | RM | Nov 15, 2024 | 29.67 | -0.20 |
Regions Financial | RF | Nov 15, 2024 | 26.36 | +0.34 |
Regions Financial B Pref | RF-B | Nov 15, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Nov 15, 2024 | 24.56 | +0.45 |
Regions Financial E Pref | RF-E | Nov 15, 2024 | 19.40 | 0.00 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Nov 15, 2024 | 26.01 | 0.00 |
Regis | RGS | Nov 15, 2024 | 17.36 | -3.56 |
Regulus Therapeutics | RGLS | Nov 15, 2024 | 1.43 | -4.67 |
Reinsurance Group of America | RGA | Nov 15, 2024 | 231.95 | +1.06 |
REIT Index ETF Vanguard | VNQ | Nov 15, 2024 | 93.80 | +0.05 |
Reitar Logtech | RITR | Nov 15, 2024 | 4.00 | 0.00 |
Rekor Systems | REKR | Nov 15, 2024 | 0.90 | -17.13 |
Relay Therapeutics | RLAY | Nov 15, 2024 | 5.11 | -8.84 |
Reliance | RS | Nov 15, 2024 | 310.44 | +0.15 |
Reliance Global | RELI | Nov 15, 2024 | 1.45 | -8.81 |
Relmada Therapeutics | RLMD | Nov 15, 2024 | 3.01 | -4.75 |
RELX ADR | RELX | Nov 15, 2024 | 44.45 | -3.26 |
Remitly Global | RELY | Nov 15, 2024 | 19.64 | -0.96 |
Renaissance Ipo ETF | IPO | Nov 15, 2024 | 44.31 | -2.16 |
RenaissanceRe | RNR | Nov 15, 2024 | 260.18 | +1.25 |
RenaissanceRe G Pref | RNR-G | Nov 15, 2024 | 18.10 | 0.00 |
RenaissanceRe Holding F Pref | RNR-F | Nov 15, 2024 | 24.43 | +0.04 |
Renalytix ADR | RNLX | Nov 15, 2024 | 0.20 | 0.00 |
Renasant | RNST | Nov 15, 2024 | 36.91 | +0.44 |
ReNew Energy Global A Shares | RNW | Nov 15, 2024 | 5.39 | +0.94 |
Renn Fund | RCG | Nov 15, 2024 | 2.31 | -2.32 |
Renovaro Biosciences | RENB | Nov 15, 2024 | 0.50 | -14.60 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.